Biotech and Delisting Risk From China's Perspective with WisdomTree
Liqian Ren, Ph.D. and director of modern alpha for WisdomTree, spoke with Dr. Peter Luo, Ph.D, co-founder and CEO of Adagene, regarding developments in the pharmaceutical industry and business practices abroad.
Source: etftrends.com